Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)
NCT00354159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 442
Last updated 2012-08-09
Summary
The purpose of this clinical research study is to evaluate the safety and effectiveness of the investigational implantable hemodynamic monitor (IHM), and of the IHM in combination with an implantable cardioverter defibrillator (ICD). The investigational IHM has the ability to record and report the force with which the heart pumps blood (heart pressures). When combined with the ICD, the device has the additional ability to send a strong electrical impulse, or shock, to the heart when it detects dangerously fast heartbeats to return it to a normal rhythm. The IHM and IHM/ICD are implanted surgically just under the skin in the upper chest area. This study will also determine how doctors use the information related to heart pressures in the management of heart failure.
Conditions
Interventions
- DEVICE
-
Implantable Hemodynamic Monitor (Chronicle® IHM), and IHM in combination with single chamber ICD (Chronicle ICD)
Surgical implantation of hemodynamic device (IHM), or IHM/ICD, and intracardiac leads.
Sponsors & Collaborators
-
Medtronic Cardiac Rhythm and Heart Failure
lead INDUSTRY
Principal Investigators
-
Phillip Adamson, MD · Oklahoma Heart Hospital
-
Michael Gold, MD · Medical University of South Carolina
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
Countries
- United States
Study Locations
More Related Trials
-
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
NCT03579641 ·Status: COMPLETED
-
PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing
NCT00409916 ·Status: UNKNOWN ·Phase: PHASE4
-
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251 ·Status: COMPLETED ·Phase: NA
-
Assessment of Combined CCM and ICD Device in HFrEF
NCT05855135 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
NCT00271154 ·Status: COMPLETED ·Phase: NA
-
Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF
NCT00158951 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ensure Cardiac Resynchronization Therapy Study
NCT00291564 ·Status: COMPLETED
-
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
NCT00180531 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures
NCT01370564 ·Status: COMPLETED ·Phase: PHASE2
-
Care-HF CArdiac Resynchronization in Heart Failure
NCT00170300 ·Status: COMPLETED ·Phase: NA
-
Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment
NCT01426321 ·Status: COMPLETED ·Phase: NA
-
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
NCT01994252 ·Status: COMPLETED ·Phase: NA
-
PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
NCT00279955 ·Status: COMPLETED
-
Renal Denervation in Heart Failure With Preserved Ejection Fraction
NCT01840059 ·Status: COMPLETED ·Phase: PHASE2
-
Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure
NCT02698241 ·Status: TERMINATED ·Phase: NA
-
Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study
NCT00632372 ·Status: COMPLETED
-
Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy
NCT04157205 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
His Bundle Pacing in Bradycardia and Heart Failure
NCT03008291 ·Status: RECRUITING
-
Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.
NCT00399594 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
NCT00345592 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
NCT00538356 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure
NCT01486316 ·Status: COMPLETED ·Phase: NA
-
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
NCT05652218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
NCT00359372 ·Status: COMPLETED
-
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
NCT02656329 ·Status: TERMINATED ·Phase: PHASE3